Market size in 2024 | US$ 345.6 million |
Forecast Market size by 2030 | US$ 485.4 million |
---|---|---|---|
Growth Rate | CAGR of 5.8% | Number of Pages | 205 Pages |
Europe Niacinamide market size was valued at US$ 345.6 million in 2024 and is projected to reach US$ 485.4 million by 2030, at a CAGR of 5.8% during the forecast period 2024-2030.
Vitamin B3 form used in skincare and nutrition.
Cosmetics industry (50%,
Report Attributes | Report Details |
---|---|
Report Title | Europe Niacinamide Market Outlook and Forecast 2024-2030 |
Market size in 2024 | US$ 345.6 million |
Forecast Market size by 2030 | US$ 485.4 million |
Growth Rate | CAGR of 5.8% |
Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year | 2023 |
Forecast Year | 2031 |
Number of Pages | 205 Pages |
Customization Available | Yes, the report can be customized as per your need. |
1.1 Product Overview and Scope of Niacinamide
1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Pharmaceutical & Cosmetic Grade
1.2.3 Feed Grade
1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Feed Additives
1.3.3 Food and Drinks
1.3.4 Pharmaceutical
1.3.5 Daily Chemicals
1.3.6 Cosmetics
1.4 Europe Market Growth Prospects
1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)
1.4.2 Europe Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Europe Production by Manufacturers (2019-2023)
3.2 Europe Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Europe Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Europe 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Europe Production
4.1.1 Europe Production YoY Growth Rate (2019-2023)
4.1.2 Europe Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Europe
5.1.1 Europe Consumption by Country
5.1.2 Europe Sales, Consumption, Export, Import (2019-2023)
5.1.1 Germany
5.2.2 United Kingdom
5.3.3 France
5.4.4 Italy
5.5.5 Spain
5.6.6 Netherlands
5.7.7 Belgium
6.1 Europe Production Market Share by Type (2019-2024)
6.2 Europe Revenue Market Share by Type (2019-2024)
6.3 Europe Price by Type (2019-2024)
7.1 Europe Production Market Share by Application (2019-2024)
7.2 Europe Revenue Market Share by Application (2019-2024)
7.3 Europe Price by Application (2019-2024)
8.1 BASF SE
8.1.1 BASF SE Corporation Information
8.1.2 BASF SE Product Portfolio
8.1.3 BASF SE Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 BASF SE Main Business and Markets Served
8.1.5 BASF SE Recent Developments/Updates
8.2 DSM Nutritional Products
8.2.1 DSM Nutritional Products Corporation Information
8.2.2 DSM Nutritional Products Product Portfolio
8.2.3 DSM Nutritional Products Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 DSM Nutritional Products Main Business and Markets Served
8.2.5 DSM Nutritional Products Recent Developments/Updates
8.3 Evonik Industries AG
8.3.1 Evonik Industries AG Corporation Information
8.3.2 Evonik Industries AG Product Portfolio
8.3.3 Evonik Industries AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Evonik Industries AG Main Business and Markets Served
8.3.5 Evonik Industries AG Recent Developments/Updates
8.4 Lonza Group AG
8.4.1 Lonza Group AG Corporation Information
8.4.2 Lonza Group AG Product Portfolio
8.4.3 Lonza Group AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Lonza Group AG Main Business and Markets Served
8.4.5 Lonza Group AG Recent Developments/Updates
8.5 Jubilant Life Sciences
8.5.1 Jubilant Life Sciences Corporation Information
8.5.2 Jubilant Life Sciences Product Portfolio
8.5.3 Jubilant Life Sciences Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Jubilant Life Sciences Main Business and Markets Served
8.5.5 Jubilant Life Sciences Recent Developments/Updates
8.6 Vertellus Specialties Inc.
8.6.1 Vertellus Specialties Inc. Corporation Information
8.6.2 Vertellus Specialties Inc. Product Portfolio
8.6.3 Vertellus Specialties Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Vertellus Specialties Inc. Main Business and Markets Served
8.6.5 Vertellus Specialties Inc. Recent Developments/Updates
8.7 Brother Enterprises Holding Co., Ltd.
8.7.1 Brother Enterprises Holding Co., Ltd. Corporation Information
8.7.2 Brother Enterprises Holding Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Brother Enterprises Holding Co., Ltd. Main Business and Markets Served
8.7.4 Brother Enterprises Holding Co., Ltd. Recent Developments/Updates
8.8 Zhejiang Lanbo Biotechnology Co., Ltd.
8.8.1 Zhejiang Lanbo Biotechnology Co., Ltd. Corporation Information
8.8.2 Zhejiang Lanbo Biotechnology Co., Ltd. Product Portfolio
8.8.3 Zhejiang Lanbo Biotechnology Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Zhejiang Lanbo Biotechnology Co., Ltd. Main Business and Markets Served
8.8.5 Zhejiang Lanbo Biotechnology Co., Ltd. Recent Developments/Updates
8.9 Zhejiang NHU Company Ltd.
8.9.1 Zhejiang NHU Company Ltd. Corporation Information
8.9.2 Zhejiang NHU Company Ltd. Product Portfolio
8.9.3 Zhejiang NHU Company Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Zhejiang NHU Company Ltd. Main Business and Markets Served
8.9.5 Zhejiang NHU Company Ltd. Recent Developments/Updates
8.10 Shandong Hongda Biotechnology Co., Ltd.
8.10.1 Shandong Hongda Biotechnology Co., Ltd. Corporation Information
8.10.2 Shandong Hongda Biotechnology Co., Ltd. Product Portfolio
8.10.3 Shandong Hongda Biotechnology Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Shandong Hongda Biotechnology Co., Ltd. Main Business and Markets Served
8.10.5 Shandong Hongda Biotechnology Co., Ltd. Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Niacinamide
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Europe Production, Revenue Forecast (2024-2030)
13.1 Europe Forecasted Consumption of by Country
14.1 Europe Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Europe Forecasted Production of by Type (2024-2030)
14.1.2 Europe Forecasted Revenue of by Type (2024-2030)
14.1.3 Europe Forecasted Price of by Type (2024-2030)
14.2 Europe Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Europe Forecasted Production of by Application (2024-2030)
14.2.2 Europe Forecasted Revenue of by Application (2024-2030)
14.2.3 Europe Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?